EXELA TECHNOLOGIES INC (XELA) Fundamental Analysis & Valuation

NASDAQ:XELA • US30162V8054

Current stock price

1.15 USD
-0.83 (-41.92%)
At close:
1.2 USD
+0.05 (+4.35%)
After Hours:

This XELA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. XELA Profitability Analysis

1.1 Basic Checks

  • In the past year XELA has reported negative net income.
  • In the past year XELA had a positive cash flow from operations.
  • XELA had negative earnings in each of the past 5 years.
  • XELA had negative operating cash flow in 4 of the past 5 years.
XELA Yearly Net Income VS EBIT VS OCF VS FCFXELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -18.44%, XELA is doing worse than 79.76% of the companies in the same industry.
  • XELA has a Return On Invested Capital (0.64%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -18.44%
ROE N/A
ROIC 0.64%
ROA(3y)-31.16%
ROA(5y)-29.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XELA Yearly ROA, ROE, ROICXELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

  • With a Operating Margin value of 0.14%, XELA perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
  • XELA's Gross Margin of 22.23% is on the low side compared to the rest of the industry. XELA is outperformed by 73.81% of its industry peers.
  • In the last couple of years the Gross Margin of XELA has declined.
Industry RankSector Rank
OM 0.14%
PM (TTM) N/A
GM 22.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y-1.6%
XELA Yearly Profit, Operating, Gross MarginsXELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. XELA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XELA is destroying value.
  • Compared to 1 year ago, XELA has more shares outstanding
  • Compared to 1 year ago, XELA has a worse debt to assets ratio.
XELA Yearly Shares OutstandingXELA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
XELA Yearly Total Debt VS Total AssetsXELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -3.85, we must say that XELA is in the distress zone and has some risk of bankruptcy.
  • XELA has a Altman-Z score of -3.85. This is amonst the worse of the industry: XELA underperforms 89.29% of its industry peers.
  • The Debt to FCF ratio of XELA is 45.59, which is on the high side as it means it would take XELA, 45.59 years of fcf income to pay off all of its debts.
  • XELA has a Debt to FCF ratio (45.59) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 45.59
Altman-Z -3.85
ROIC/WACC0.08
WACC8.14%
XELA Yearly LT Debt VS Equity VS FCFXELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.38 indicates that XELA may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.38, XELA is doing worse than 95.24% of the companies in the same industry.
  • XELA has a Quick Ratio of 0.38. This is a bad value and indicates that XELA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.35, XELA is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.35
XELA Yearly Current Assets VS Current LiabilitesXELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. XELA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.10% over the past year.
  • Looking at the last year, XELA shows a decrease in Revenue. The Revenue has decreased by -5.15% in the last year.
  • Measured over the past years, XELA shows a decrease in Revenue. The Revenue has been decreasing by -7.67% on average per year.
EPS 1Y (TTM)97.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.63%
Revenue 1Y (TTM)-5.15%
Revenue growth 3Y-6.28%
Revenue growth 5Y-7.67%
Sales Q2Q%-9.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XELA Yearly Revenue VS EstimatesXELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
XELA Yearly EPS VS EstimatesXELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

Find the best growth stocksShow best growing peers

2

4. XELA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XELA. In the last year negative earnings were reported.
  • Also next year XELA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XELA Price Earnings VS Forward Price EarningsXELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • 60.71% of the companies in the same industry are more expensive than XELA, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, XELA is valued cheaper than 98.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.31
EV/EBITDA 17.97
XELA Per share dataXELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XELA Dividend Analysis

5.1 Amount

  • No dividends for XELA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

XELA Fundamentals: All Metrics, Ratios and Statistics

EXELA TECHNOLOGIES INC

NASDAQ:XELA (11/7/2024, 8:12:48 PM)

After market: 1.2 +0.05 (+4.35%)

1.15

-0.83 (-41.92%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-06
Earnings (Next)11-28
Inst Owners8.43%
Inst Owner Change0%
Ins Owners1296.91%
Ins Owner Change0%
Market Cap7.33M
Revenue(TTM)1.02B
Net Income(TTM)-108.41M
Analysts43.33
Price Target2.04 (77.39%)
Short Float %N/A
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.37
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.31
P/OCF 0.2
P/B N/A
P/tB N/A
EV/EBITDA 17.97
EPS(TTM)-17.03
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)3.73
FCFY324.44%
OCF(TTM)5.7
OCFY495.67%
SpS160.44
BVpS-141.88
TBVpS-191.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.44%
ROE N/A
ROCE 0.82%
ROIC 0.64%
ROICexc 0.78%
ROICexgc N/A
OM 0.14%
PM (TTM) N/A
GM 22.23%
FCFM 2.33%
ROA(3y)-31.16%
ROA(5y)-29.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y-1.6%
F-Score6
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 45.59
Debt/EBITDA 17.34
Cap/Depr 21.79%
Cap/Sales 1.23%
Interest Coverage 0.02
Cash Conversion 61.52%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.35
Altman-Z -3.85
F-Score6
WACC8.14%
ROIC/WACC0.08
Cap/Depr(3y)23.88%
Cap/Depr(5y)21.7%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.63%
EPS Next Y-18.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.15%
Revenue growth 3Y-6.28%
Revenue growth 5Y-7.67%
Sales Q2Q%-9.98%
Revenue Next Year5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year295.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y137.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y192.16%
OCF growth 3YN/A
OCF growth 5Y-31.51%

EXELA TECHNOLOGIES INC / XELA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EXELA TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 1 / 10 to XELA.


What is the valuation status for XELA stock?

ChartMill assigns a valuation rating of 2 / 10 to EXELA TECHNOLOGIES INC (XELA). This can be considered as Overvalued.


What is the profitability of XELA stock?

EXELA TECHNOLOGIES INC (XELA) has a profitability rating of 1 / 10.


What is the expected EPS growth for EXELA TECHNOLOGIES INC (XELA) stock?

The Earnings per Share (EPS) of EXELA TECHNOLOGIES INC (XELA) is expected to decline by -18.13% in the next year.